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Abstract
Background: Early-onset depressive disorders can have severe consequences both from developmental and
functional aspects. The etiology of depressive disorders is complex and multi-factorial, with an intricate interaction
among environmental factors and genetic predisposition. While data from studies on adults suggest that caffeine is
fairly safe, effects of caffeine in children, who are in period of rapid brain development, are currently unknown.
Furthermore, systematic research addressing the relationship between depressive symptoms in children and
caffeine consumption is lacking.
The present study examined the effects of caffeine consumption on depressed mood in children with depression
and non-depressed participants.
Methods: Children and adolescents (n = 51) already enrolled in an ongoing longitudinal study, aged 9-12 years,
were assessed for depressive symptoms with the Children Depressive Inventory (CDI). Psychopathological
symptoms were assessed with the Child Behavioral Checklist (CBCL) and eating habits were assessed with the
Nutrition-Behavior Inventory (NBI) [1]. The children were compared to control children without psychopathology
attending public schools in a Southern Brazilian city.
Results: Participants with CDI scores ≥ 15 (mean = 19; S.D. = 4) also had high NBI scores (mean = 52; S.D. = 19, p
< 0.001) suggestive of a relationship between depressive symptoms and environmental factors, in this case
nutrition/behavior. Additional linear regression adjusted statistical analysis, considering the factors of consumption
of sweets and caffeine individually, showed that caffeine, but not sweets, was associated with depressive
symptoms.
Conclusions: These findings indicate that depressed children consume more caffeinated drinks than non-
depressed children. Nonetheless while a strong association between depressive symptoms and caffeine
consumption among children was found, further research should investigate whether or not this association is due
to a cause and effect relationship.
Background
The etiology of childhood depression is complex and
not fully understood. Depressive disorders can result
from an interaction between neurobiological, genetic,
psychological and social factors. There is a growing
body of evidence that environmental variables in combi-
nation with genetics may play a fundamental role in the
development of this disorder.
There has been a steady increase in caffeine consump-
tion among youngsters over the years with an estimated
75-98% consuming at least one caffeinated beverage
daily [2,3]. However, few empirical studies have
addressed the possible link between consumption of caf-
feinated drinks and the development of behavioral and
mood disorders in children [3]. Studies have shown that
on average children and adolescents consume two 12 oz
cans of soda daily [4,5], each containing 20 to 55 mg of
caffeine. In addition, there is a new market for youth-
directed “energetic drinks” which stimulate both the
peripheral and central nervous systems. The usage of
these drinks and the psychiatric and long term
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needs to be addressed by empirical research.
Prior studies have found that adolescents with caffeine
dependence report a greater level of anxious and depres-
sive symptoms [6,7]. A recent study reported that
youths diagnosed with major depressive disorder con-
sumed more caffeine and complained of more sleep pro-
blems than youths without depression [8]. To further
address this issue we examined whether children with
depression consumed more caffeine containing bev-
erages than matched healthy controls.
Methods
Participants
The present investigation was part of an ongoing longi-
tudinal clinical assessment of behavioral, mood, and
learning disorders conducted in our Research Institute
[9,10]. This study included 51 children recruited from
local public schools, 1
st to 5
th grade. Through lectures
at the public schools, teachers were encouraged to iden-
tify students with suspected learning difficulties, mood
disorders, attention problems, and hyperactive behavior.
The teachers were also informed about the availability
of research evaluations via referral to our Research
Institute.
Boys often display more externalizing problems, such
as aggressive and defiant behaviors, and therefore tend
to be clinically referred by teachers more often than
girls [11]. Thus, our sample was composed of mostly
males (84% male vs. 16% female). Furthermore, all of
the subjects were from the same public schools as well
as the same socio-economic (lower middle) class. Thus,
it is reasonable to assume that confounding lifestyle
variables should be minimal. Parents accompanying
their children provided written informed consent and
the children entered a multi-stage, multi-method assess-
ment process to establish diagnostic groups.
Procedures and Assessments
Depressive symptoms were measured using the Children
Depression Inventory (CDI). The CDI is a widely uti-
lized and well-studied clinical and research tool in the
assessment of depressive symptoms in children and ado-
lescents from seven to 17 years of age. The CDI is self-
administered and contains 27 items. Responses to each
item range from 0-2, 0 = absence of the symptom, 1 =
moderate symptom, and 2 = severe symptom [12]. A
total CDI score of ≥15 was used as the cut-off score for
major depressive disorder [13]. Additional information
regarding depressive symptoms as well as the presence
of other psychopathologies was obtained through the
Child Behavior Checklist (CBCL) [14]. A computer
based CBCL was used to convert raw scores to age and
gender-standardized T scores. A T score ≥ 70 indicates
98
th percentile of the normative sample [14].
Participants received thorough medical evaluations
that included neurological, ophthalmological and audio-
logical examinations to rule out perceptual disorders.
Full-scale IQ was measured using the Wechsler Intelli-
gence Scale for children, 3
rd edition [15]. Subjects with a
full-scale IQ ≤ 70 that were < 9 years of age were not
included in the study. Inclusion criteria for the depres-
s i v eg r o u pi n c l u d e dm e e t i n gf u l lD S M - I V - T Rc r i t e r i a
[16] and the absence of medication. The controls were
children who did not meet criteria for any DSM psycho-
pathology, and who had no other physical conditions,
such as epilepsy.
Assessment of dietary behavior was obtained using the
Nutrition-Behavior-Inventory (NBI) [1,17]. The NBI is a
pencil-and-paper test, with 52 questions used in the
assessment of the relationship between aspects of nutri-
tion (in particular eating habits) and psychological
symptoms of behavior. Responses are made in a likert
format (0-never, 1-occasionally, 2-often, and 3-always).
A total NBI score ≥ 30 has been suggested as an indica-
tor of an association between psychological symptoms
and eating habits. In addition to analyzing total NBI
score, we also analyzed three specific questions regard-
ing consumption of sweets and caffeine containing
drinks.
The study protocol was reviewed and approved by our
research Ethics Committee on Human Research at the
Little Prince Children’s Hospital, Curitiba, Brazil.
Statistical Analyses
The data were analyzed using the software Statistica-7.0
(StatSoft
®South America) using the Student’s t-test to
compare data from children with a CDI≥15 versus a
CDI <15. An analysis of covariance (ANCOVA) and
multiple linear regression analysis were performed to
control for possible confounding variables regarding the
association of consumption of caffeinated drinks and
depressive symptoms and consumption of sweets. Addi-
tionally, the Fisher’se x a c tt e s tw a su s e dt od e t e r m i n e
the differences between the higher and lower consump-
tion groups. The statistical significance level was set at p
< 0.05.
Results
The clinical and demographic characteristics of the
groups are presented in Table 1. No significant differ-
ences were found in age and sex distribution between
the depression and control groups. The Full-scale
WISC-III IQ scores did not differ significantly between
the depressed group and the controls (p = 0.32). Chil-
dren with depression presented significantly higher T
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Total Problems (p < 0.005).
Children with higher CDI scores (n = 34, 19.7 ± 4,
mean ± SD), who met the diagnostic criteria for depres-
sion, showed higher NBI scores (52 ± 19, mean ± SD)
(p < 0.001) (Figure 1). When ANCOVA analyses were
carried out considering sugar consumption, caffeine
consumption, and sugar/caffeine consumption as covari-
ates, the difference persisted (p < 0.001). However, after
adjusted statistical analyses, in linear regression, consid-
ering the factors of sweet and caffeine consumption
separately, only caffeine consumption was associated
with depressive symptoms (R
2 = 0.530; b =1 . 6 4 0 ;p=
0.031).
The association between caffeine consumption and
NBI scores is depicted in Figure 2. All children with caf-
feine consumption classified as “often” or “always” had
CDI scores higher than 15. The comparison between
children who reported never drinking caffeine versus
those who had caffeine consumption classified as “some-
times”, “often”,o r“always” showed that the percentage
of children with a CDI score <15 was significantly
higher in the group without caffeine consumption (p <
0.001).
Discussion
The present study found an association between the
consumption of caffeinated drinks and clinical depres-
sion in children. However, a cause-effect relationship
cannot be determined due to the correlational nature of
the data. In fact, very few empirical studies have pre-
viously addressed this issue. We cannot determine
whether the high consumption of caffeine in our study
population was actually “causing” depression or if high
consumption was used to relieve some symptoms of
depression. It is possible that children meeting diagnos-
tic criteria for major depression use caffeine to “self-
medicate” to ease the symptoms associated with depres-
sion. Studies have shown that adults often use sub-
stances to alleviate psychiatric symptoms [18]. In
addition, caffeine usage has been moderately associated
with a genetic predisposition for major depression, anxi-
ety and substance use disorders [19]. It is therefore pos-
sible that the depressed youth in the current study may
ingest caffeine and sweets for temporary relief [7].
The issue of a link between externalizing problems
and depression, may be less intuitive. However, studies
have shown that depressive symptoms in children are
present somewhat differently than in adults. Children
frequently show “irritability and aggressiveness”,w h i c h
may be perceived as “externalizing behaviors” by parents
and teachers; thus their CBCL-T-scores on the externa-
lizing scale may be high [20,21].
The primary vehicle for caffeine consumption in chil-
dren is soft drinks, which generally also contain a large
amount of sugar [22]. Accordingly, in this study we also
found a correlation between depression and the con-
sumption of sweets and colas. Studies have shown that
sugar, like caffeine, activates dopaminergic reward
Table 1 Demographic and Clinical Characteristics of the
Sample: Means ± Standard Deviation
DEPRESSION CONTROLS p
n=3 4 n=1 7
Gender (% boys) 88.2% 76.5% 0.30
Age (years) 9.9 (1.0) 9.9 (1.4) 0.86
NBI 52.4 (18.8) 26.1 (12.6) 0.0001*
CDI 19.7(4.0) 9.9 (1.4) 0.0001*
WISC-III FS IQ 95.1 (16.0) 108.1 (24) 0.32
CBCL (T score)
Internalizing Problems 67.2 (11.6) 58.9 (7.5) 0.005*
Externalizing Problems 69.4 (9.3) 56.1 (8.0) 0.0001*
Total Problems 71.4 (7.1) 58.6 (5.4) 0.0001*
NBI: Nutrition Behavior Inventory; CDI: Children Depression Inventory; WISC-III
FS IQ: Wechsler Intelligence Scale for Children, 3rd Ed. Full Scale IQ; CBCL:
Children Behavior Checklist; *statistically significant.
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Figure 1 Children who met diagnostic criteria for Depression
also had higher scores on Nutrition Behavior Inventory-NBI (p
< 0.001).
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Figure 2 NBI question #27 “I drink more than 3 cups of coffee,
cola or tea per day"; Categories were compared by means
Fisher’s exact test. The “never” category was significantly different
from each of the other categories (p < 0.001).
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such as cocaine [23-25]. Therefore caffeine in soft drinks
may act synergistically on the dopaminergic system, with
the high levels of sugar in the drinks.
It is well documented that caffeine consumption in
adults increases alertness and leads to high cognitive
performance [26,27]. However, studies have also shown
that high caffeine consumption can trigger anxiety and
depressive-like conditions [28,29]. It has been postulated
that caffeine at nontoxic doses acts as a competitive
antagonist to the adenosine A1 and A2 receptors [30]
and studies have shown that adenosine interacts with
dopamine DRD2 receptors [31,32] as well as with gluta-
matergic neurotransmission [33]. Both the dopaminergic
and gluatmatergic systems have been implicated in psy-
chiatric disorders (mood disorders). The adenosine A1
receptor subtype is inhibitory while the A2 subtype is
facilitatory. Since caffeine acts at both adenosine recep-
tor subtypes, some authors have argued that caffeine at
different concentrations may have opposing effects by
acting at different receptors subtypes [34]. Other studies
suggest a J-shaped caffeine dosage curve as an indepen-
dent risk factor for suicide [35]. In fact these researchers
have shown that caffeine consumption at low to moder-
ate doses may have protective effects. For example, they
found that moderate caffeine consumers had a lower
risk of suicide, while heavy coffee drinkers (> 8 cups/
day) had a greater risk for suicide [35]. Furthermore,
other researchers have found that daily caffeine con-
sumption of up to 140 mg is associated with a reduced
risk of depression [36].
Studies in school children have shown that high caf-
feine consumers (> 50 mg/day) had significantly more
negative-effect symptoms than low consumers (< 10
mg/day) [37]. More recent studies have also shown that
caffeine-dependent adolescents had a significantly higher
score on self-reports of anxiety and depression than a
non-dependent group [6]. Interestingly, some studies
have also linked the abuse of other drugs with caffeine
consumption. Bernestein and colleagues (2002) showed
that adolescents dependent on marijuana consumed sig-
nificantly more caffeine than non-marijuana dependent
controls. Earlier studies have shown that alcohol, mari-
juana, and amphetamine abusers have a greater likeli-
hood of coffee drinking by 12 years of age when
compared to non-abusers [38]. It is therefore important
for parents to closely monitor their children’sc o n s u m p -
tion habits as a possible indicator of mood, behavior,
and/or addictive problems on the rise.
The methods used in the current study present a
number of limitations. First, we did not measure the
actual average daily intake of caffeine or carbohydrates.
We estimated consumption based on self-reported items
on the NBI which is based on a likert scale. Second, our
results should be considered preliminary due to the
small sample size. Third, more male subjects than
female subjects participated in the study and thus we
cannot generalize our results to the young female
population.
Conclusions
In conclusion, our data suggest that depressed children
consume more caffeinated drinks than non-depressed
children. However, further studies of caffeine consump-
tion in children, especial l yt h o s ew h om a yb ep r e d i s -
posed to major depression, are warranted. Furthermore,
since previous studies have also suggested that early caf-
feine consumption may be an indication of later drug
abuse, it is worthwhile for parents to monitor the daily
eating and drinking habits of their children. The ques-
tion as to whether high caffeine consumption may actu-
ally cause symptoms of depression or ease the
symptoms of depression in children remains unknown.
However, the results presented here warrant further
investigations to prevent this serious psychiatric disorder
from developing.
Understanding the relationship of multiple factors
associated with childhood depression may lead to the
identification of those at risk and the establishment of
preventive protocols and early interventions.
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